211 related articles for article (PubMed ID: 21547707)
1. Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Kobayashi H; Sueda T
J Gastrointest Surg; 2011 Jun; 15(6):1007-16. PubMed ID: 21547707
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
[TBL] [Abstract][Full Text] [Related]
3. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection?
Sakata J; Kobayashi T; Ohashi T; Hirose Y; Takano K; Takizawa K; Miura K; Ishikawa H; Toge K; Yuza K; Soma D; Ando T; Wakai T
Eur J Surg Oncol; 2017 Apr; 43(4):780-787. PubMed ID: 28132788
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
Ann Surg; 2009 Dec; 250(6):950-6. PubMed ID: 19953713
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the gallbladder: an appraisal of surgical resection.
Chijiiwa K; Tanaka M
Surgery; 1994 Jun; 115(6):751-6. PubMed ID: 7910985
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location.
Toge K; Sakata J; Hirose Y; Yuza K; Ando T; Soma D; Katada T; Miura K; Takizawa K; Kobayashi T; Wakai T
Eur J Surg Oncol; 2019 Aug; 45(8):1446-1452. PubMed ID: 30962045
[TBL] [Abstract][Full Text] [Related]
7. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.
He XD; Li JJ; Liu W; Qu Q; Hong T; Xu XQ; Li BL; Wang Y; Zhao HT
World J Gastroenterol; 2015 Apr; 21(15):4620-6. PubMed ID: 25914471
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
J Gastrointest Surg; 2009 Aug; 13(8):1470-9. PubMed ID: 19421824
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes of minor hepatectomy for locally advanced gallbladder carcinoma.
Wakai T; Shirai Y; Sakata J; Tsuchiya Y; Nomura T; Hatakeyama K
Hepatogastroenterology; 2012 Oct; 59(119):2083-8. PubMed ID: 22456433
[TBL] [Abstract][Full Text] [Related]
10. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification.
Shimizu H; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
J Hepatobiliary Pancreat Surg; 2007; 14(4):358-65. PubMed ID: 17653633
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
[TBL] [Abstract][Full Text] [Related]
12. A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma.
Kai M; Chijiiwa K; Ohuchida J; Nagano M; Hiyoshi M; Kondo K
J Gastrointest Surg; 2007 Aug; 11(8):1025-32. PubMed ID: 17508256
[TBL] [Abstract][Full Text] [Related]
13. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.
Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Hepatogastroenterology; 2012; 59(113):36-41. PubMed ID: 22251521
[TBL] [Abstract][Full Text] [Related]
14. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer.
Todoroki T; Kawamoto T; Otsuka M; Koike N; Yoshida S; Takada Y; Adachi S; Kashiwagi H; Fukao K; Ohara K
Hepatogastroenterology; 1999; 46(27):1585-91. PubMed ID: 10430299
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection.
Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
J Gastrointest Surg; 2010 Apr; 14(4):668-78. PubMed ID: 20033339
[TBL] [Abstract][Full Text] [Related]
16. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival.
Todoroki T; Takahashi H; Koike N; Kawamoto T; Kondo T; Yoshida S; Kashiwagi H; Otsuka M; Fukao K; Saida Y
Hepatogastroenterology; 1999; 46(28):2114-21. PubMed ID: 10521952
[TBL] [Abstract][Full Text] [Related]
18. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion.
Endo I; Shimada H; Fujii Y; Sugita M; Masunari H; Miura Y; Tanaka K; Misuta K; Sekido H; Togo S
J Hepatobiliary Pancreat Surg; 2001; 8(6):505-10. PubMed ID: 11956900
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine-based adjuvant chemotherapy for patients with advanced gallbladder cancer.
Nakamura M; Nakashima H; Abe T; Ensako T; Yoshida K; Hino K
Anticancer Res; 2014 Jun; 34(6):3125-9. PubMed ID: 24922682
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
